Zhejiang Qianjiang Biochemical Co., Ltd (SHA:600796)
China
· Delayed Price · Currency is CNY 6.36
+0.12 (1.92%)
Apr 29, 2026, 3:00 PM CST
SHA:600796 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,694 | 1,765 | 2,031 | 2,004 | 2,020 | Upgrade
|
| Other Revenue | - | 3.58 | 3.74 | 4.46 | 11.06 | Upgrade
|
| Revenue | 1,694 | 1,768 | 2,034 | 2,009 | 2,031 | Upgrade
|
| Revenue Growth (YoY) | -4.22% | -13.08% | 1.27% | -1.08% | 7.55% | Upgrade
|
| Cost of Revenue | 1,275 | 1,364 | 1,556 | 1,569 | 1,564 | Upgrade
|
| Gross Profit | 418.55 | 404.83 | 478.75 | 439.57 | 466.59 | Upgrade
|
| Selling, General & Admin | 136.9 | 159.79 | 166.45 | 150.15 | 136.98 | Upgrade
|
| Research & Development | 27.85 | 29.83 | 28.41 | 31.45 | 32.03 | Upgrade
|
| Other Operating Expenses | 10.27 | 3.76 | -0.49 | 6.83 | 3.17 | Upgrade
|
| Operating Expenses | 175.02 | 236.11 | 213.37 | 190.37 | 175.12 | Upgrade
|
| Operating Income | 243.53 | 168.72 | 265.38 | 249.2 | 291.48 | Upgrade
|
| Interest Expense | - | -78.71 | -89.12 | -92.43 | -75.36 | Upgrade
|
| Interest & Investment Income | 52.68 | 75.36 | 60.54 | 70.34 | 5.32 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.05 | 0.66 | 1.72 | 1.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -93.71 | -7.4 | -10.2 | -15.19 | -18.54 | Upgrade
|
| EBT Excluding Unusual Items | 202.51 | 159.02 | 227.26 | 213.63 | 204.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.99 | 0.89 | 9.1 | 9.52 | 0.51 | Upgrade
|
| Asset Writedown | -3.09 | 1.34 | -9.26 | -3.01 | - | Upgrade
|
| Other Unusual Items | - | 13.09 | 1.73 | 20.12 | 4.62 | Upgrade
|
| Pretax Income | 201.4 | 174.33 | 228.84 | 240.27 | 209.73 | Upgrade
|
| Income Tax Expense | 45.76 | 48.98 | 45.94 | 50.17 | 46.98 | Upgrade
|
| Earnings From Continuing Operations | 155.65 | 125.35 | 182.9 | 190.1 | 162.75 | Upgrade
|
| Minority Interest in Earnings | 10.72 | 34.65 | 27.79 | 15.95 | -14.81 | Upgrade
|
| Net Income | 166.36 | 160 | 210.69 | 206.05 | 147.94 | Upgrade
|
| Net Income to Common | 166.36 | 160 | 210.69 | 206.05 | 147.94 | Upgrade
|
| Net Income Growth | 3.98% | -24.06% | 2.25% | 39.28% | 53.89% | Upgrade
|
| Shares Outstanding (Basic) | 876 | 889 | 878 | 859 | 672 | Upgrade
|
| Shares Outstanding (Diluted) | 876 | 889 | 878 | 859 | 672 | Upgrade
|
| Shares Change (YoY) | -1.50% | 1.26% | 2.25% | 27.67% | 4.92% | Upgrade
|
| EPS (Basic) | 0.19 | 0.18 | 0.24 | 0.24 | 0.22 | Upgrade
|
| EPS (Diluted) | 0.19 | 0.18 | 0.24 | 0.24 | 0.22 | Upgrade
|
| EPS Growth | 5.56% | -25.00% | - | 9.09% | 46.67% | Upgrade
|
| Free Cash Flow | 178.82 | -446.07 | 117.73 | 34.38 | -199.62 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | -0.50 | 0.13 | 0.04 | -0.30 | Upgrade
|
| Dividend Per Share | - | 0.031 | 0.031 | 0.102 | 0.100 | Upgrade
|
| Dividend Growth | - | - | -69.61% | 2.00% | - | Upgrade
|
| Gross Margin | 24.71% | 22.89% | 23.53% | 21.88% | 22.98% | Upgrade
|
| Operating Margin | 14.38% | 9.54% | 13.05% | 12.40% | 14.35% | Upgrade
|
| Profit Margin | 9.82% | 9.05% | 10.36% | 10.26% | 7.28% | Upgrade
|
| Free Cash Flow Margin | 10.56% | -25.22% | 5.79% | 1.71% | -9.83% | Upgrade
|
| EBITDA | 436.18 | 402.05 | 490.69 | 484.82 | 473.82 | Upgrade
|
| EBITDA Margin | 25.75% | 22.74% | 24.12% | 24.13% | 23.33% | Upgrade
|
| D&A For EBITDA | 192.65 | 233.33 | 225.31 | 235.62 | 182.35 | Upgrade
|
| EBIT | 243.53 | 168.72 | 265.38 | 249.2 | 291.48 | Upgrade
|
| EBIT Margin | 14.38% | 9.54% | 13.05% | 12.40% | 14.35% | Upgrade
|
| Effective Tax Rate | 22.72% | 28.09% | 20.08% | 20.88% | 22.40% | Upgrade
|
| Revenue as Reported | - | 1,768 | 2,034 | 2,009 | 2,031 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.